KALV vs VRTX: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Vertex Pharmaceuticals Inc in 2026
KALV
Kalvista Pharmaceuticals Inc
$19.56
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | KALV | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.07B | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.3% | 0.1% | KALV |
| Gross Margin | 25.7% | 53.7% | VRTX |
Analyze KALV
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or VRTX a better investment?
Comparing KALV and VRTX: Kalvista Pharmaceuticals Inc has a market cap of $1.07B while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and VRTX?
KALV (Kalvista Pharmaceuticals Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or VRTX?
KALV has higher revenue growth at 0.3% vs 0.1% for VRTX.
Which company is more profitable: KALV or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 25.7% for KALV.
Which is the larger company: KALV or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $1.07B for KALV.
Should I buy KALV or VRTX in 2026?
Both KALV and VRTX have investment merit. KALV trades at $19.56 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and VRTX stock?
Key differences: Market Cap ($1.07B vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (0.3% vs 0.1%), Gross Margin (25.7% vs 53.7%).